{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:35:32Z","timestamp":1786793732198,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T00:00:00Z","timestamp":1524268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.alit.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T08:38:27Z","timestamp":1525941507000},"page":"S3-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"S","title":["Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma"],"prefix":"10.1016","volume":"67","author":[{"given":"Tomoyuki","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Iemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Nakagome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2018.04.003_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2018.04.003_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"EurRespir J"},{"key":"10.1016\/j.alit.2018.04.003_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2010.02.008","article-title":"National Heart, Lung, and Blood Institute Severe Asthma Research Program. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes","volume":"125","author":"Hastie","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.alit.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201408-1440OC","article-title":"Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma","volume":"191","author":"Yan","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib7","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jaci.2016.08.048","article-title":"U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics","volume":"139","author":"Lefaudeux","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2018.04.003_bib10","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2018.04.003_bib12","first-page":"CD003559","article-title":"Omalizumab for asthma in adults and children","volume":"1","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2018.04.003_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaip.2014.03.010","article-title":"Omalizumab in asthma: an update on recent developments","volume":"2","author":"Humbert","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2018.04.003_bib14","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2018.04.003_bib15","first-page":"CD005603","article-title":"Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults","volume":"8","author":"Petsky","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2018.04.003_bib16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jaci.2017.10.005","article-title":"Biomarkers for severe eosinophilic asthma","volume":"140","author":"Yancey","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","article-title":"Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma","volume":"11","author":"Katz","year":"2014","journal-title":"Ann Am ThoracSoc"},{"key":"10.1016\/j.alit.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/thx.2009.124925","article-title":"Exhaled nitric oxide thresholds associated with a sputum eosinophil count \u22653% in a cohort of unselected patients with asthma","volume":"65","author":"Schleich","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2018.04.003_bib21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaci.2014.09.034","article-title":"High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma","volume":"135","author":"Fowler","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2018.04.003_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2013.02.032","article-title":"High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects","volume":"132","author":"Busse","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/cea.12345","article-title":"Full blood count parameters for the detection of asthma inflammatory phenotypes","volume":"44","author":"Zhang","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2018.04.003_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2013.07.036","article-title":"Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma","volume":"133","author":"Peters","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.alit.2017.02.003","article-title":"KiHAC Respiratory Medicine Group. Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma","volume":"66","author":"Nagasaki","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2018.04.003_bib28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2018.04.003_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chest.2017.01.021","article-title":"Hematopoietic processes in eosinophilic asthma","volume":"152","author":"Salter","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.alit.2018.04.003_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1513\/AnnalsATS.201609-720OC","article-title":"Serum periostin as a biomarker for comorbid chronic rhinosinusitis in patients with asthma","volume":"14","author":"Asano","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.alit.2018.04.003_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaip.2014.06.005","article-title":"High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma","volume":"2","author":"Zeiger","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2018.04.003_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Me"},{"key":"10.1016\/j.alit.2018.04.003_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"National heart, lung, and blood institute's severe asthma research program-3 investigators. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200905-0695OC","article-title":"National Heart, Lung, and Blood Institute Severe Asthma Research Program. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma","volume":"181","author":"Dweik","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib35","article-title":"Exhaled nitric oxide levels to guide treatment for adults with asthma","volume":"9","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2018.04.003_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2013.06.007","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subject","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.11-RAI-0327","article-title":"Japanese guideline for adult asthma","volume":"60","author":"Ohta","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2018.04.003_bib38","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2015. Available at: http:\/\/www.ginasthma.org."},{"key":"10.1016\/j.alit.2018.04.003_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib40","first-page":"319","article-title":"Standardization of spirometry, ATS\/ERS task force","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2018.04.003_bib41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","author":"American Thoracic Society; European Respiratory Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib42","first-page":"3s","article-title":"Sputum induction","volume":"37","author":"Paggiaro","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2018.04.003_bib43","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1164\/ajrccm.163.6.9901105","article-title":"Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study","volume":"163","author":"Fahy","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40733-016-0021-y","article-title":"CXC chemokine superfamily induced by Interferon-\u03b3 in asthma: a cross-sectional observational study","volume":"2","author":"Takaku","year":"2016","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.alit.2018.04.003_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2013.03.044","article-title":"National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects","volume":"132","author":"Hastie","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib46","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/cea.12792","article-title":"Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study","volume":"46","author":"Mogensen","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2018.04.003_bib47","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaci.2016.01.044","article-title":"Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity","volume":"138","author":"Malinovschi","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.alit.2018.04.003_bib49","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","article-title":"Asthma clinical research network of the national heart, lung, and blood institute. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic","volume":"185","author":"McGrath","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2018.04.003_bib50","doi-asserted-by":"crossref","first-page":"e90018","DOI":"10.1371\/journal.pone.0090018","article-title":"Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS","volume":"9","author":"Roos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2018.04.003_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1183\/09031936.00097412","article-title":"The influence of sensitisation to pollens and moulds on seasonal variations in asthma attacks","volume":"42","author":"Canova","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2018.04.003_bib52","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jaci.2016.06.046","article-title":"Associations between outdoor fungal spores and childhood and adolescent asthma hospitalizations","volume":"139","author":"Tham","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.04.003_bib53","series-title":"Exhaled Biomarkers, European Respiratory Society Monograph","first-page":"1","article-title":"Basic aspects of exhaled nitric oxide","author":"Alving","year":"2010"},{"key":"10.1016\/j.alit.2018.04.003_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaci.2016.11.038","article-title":"Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study investigators. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients","volume":"140","author":"Silkoff","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893018300455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893018300455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:08:07Z","timestamp":1761156487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893018300455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":54,"alternative-id":["S1323893018300455"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2018.04.003","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}